Protagonist Stock 120%, Fund Outlook and Exit Signals
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Learn how US total market index funds can simplify retirement investing by providing broad exposure, low costs, and diversified growth opportunities.
28,342 articlesA hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
A large fund trimmed its DigitalBridge position, sparking questions about stake moves, stock momentum, and how invest...
As gold holds its bid in a backdrop of steady inflation, the iShares Gold Trust SPDR comparison centers on a 0.15% an...
A major portfolio move by Deepwater Asset Management shaved nearly half of its stake in Global-E Online. Here’s what ...
Institutions are increasingly weighing Bitcoin as a potential reserve asset alongside gold, amid macro uncertainty an...
A viral moment where a pope’s sneakers stole the spotlight isn’t just a meme. It’s a teachable moment about money cho...
A high-profile moment collides Hollywood, politics, and money. This article uses exactly brett ratner and Melania as ...
Brian Niccol's Starbucks just embarked on an ambitious turnaround driven by technology and service upgrades. This art...
Britain’s top spy says the window to outpace adversaries is shrinking, pushing cybersecurity to the forefront of pers...
When cultural moments go big, your wallet pays attention. This article breaks down how Pink and Queen Latifah are exp...
Fame often comes with hidden costs. In this piece, we unpack Cara Delevingne's reflections on her Victoria’s Secret y...
A new working paper suggests a measurable dip in U.S. births where smartphones are widespread, raising questions abou...